MP Biomedicals announces the launch of advanced gastrointestinal diseases diagnostic kits

FHS
August 27, 2024
11:17 am

MP Biomedicals completes its range of in vitro diagnostic tests for infectious diseases with new immunochromatographic-based qualitative rapid tests.The new diagnostic kits by MP Biomedicals leverage cutting-edge technology to deliver precise results, enabling healthcare professionals a rapid and accurate detection of Helicobacter pylori, Salmonella typhi and Vibrio cholerae serogroups O1 and O139.

FDA Expands Enhertu Approval to HER2-Ultralow Breast Cancer

The FDA expanded the approval of trastuzumab deruxtecan (T-DXd, Enhertu) to include treatment of unresectable/metastatic hormone receptor (HR)-positive, HER2-low/ultralow breast cancer. Approval stipulates use in

January 29, 2025

America Is Trying to Fix Its Maternal Mortality Crisis With Government Programs

TULSA, Okla. — At the site of a race massacre that reduced neighborhoods to ashes a century ago, where murals memorialize a once-thriving “Black Wall

September 6, 2024

Four years after completion, a RiNo office building is still empty – The Cannabist

Related Articles The best real estate decision that Ed Haselden said he ever made didn’t bring him riches. He and his partners made no profit

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.